NCT05173298 2024-02-07
HCC
CHA University
Unknown
Clinical Trials
17 trialsNCT03647592 2023-12-27
Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
Unknown
NCT03451370 2023-11-29
COBRA
Istituto Oncologico Veneto IRCCS
Unknown
NCT04107168 2023-02-16
Microbiome Immunotherapy Toxicity and Response Evaluation
Cambridge University Hospitals NHS Foundation Trust
Unknown
NCT05177666 2022-01-04
a Prospective Registration Study for Patients With Advanced Refractory Solid Tumors
The University of Hong Kong-Shenzhen Hospital
Unknown
NCT04788381 2021-03-09
The Effects of Preoperative Bevacizumab on Perioperative Complications
Second Affiliated Hospital, School of Medicine, Zhejiang University
Unknown
NCT04575415 2020-10-20
BELLA
Guangdong Association of Clinical Trials
Unknown
NCT04213222 2020-08-11
ROBOT
Peking University People's Hospital
Unknown
NCT03925233 2019-04-24
Breast Cancer Treatment Based on Organ-like Culture
Xijing Hospital
Unknown
NCT03923036 2019-04-22
AVOCETTE
University Hospital, Caen
Unknown
NCT03195569 2017-06-22
To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd.
Unknown
NCT02842294 2016-07-22
COBEQOL
Centre Hospitalier Universitaire de Besancon
Unknown
NCT01860144 2015-05-19
An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer
Peking University
Unknown
NCT01912443 2014-04-28
Safety Study of Bevacizumab Plus Chemotherapy To Treat Metastatic Colorectal Cancer
Sun Yat-sen University
Unknown
NCT00898794 2013-08-07
Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer
National Cancer Institute (NCI)
Unknown
NCT01891708 2013-07-03
VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer
Huazhong University of Science and Technology
Unknown
NCT01311050 2011-12-13
A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer
King Faisal Specialist Hospital & Research Center
Unknown